These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 15852200
21. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future. Clarkson TB, Meléndez GC, Appt SE. Menopause; 2013 Mar; 20(3):342-53. PubMed ID: 23435033 [Abstract] [Full Text] [Related]
22. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment. Gungor F, Kalelioglu I, Turfanda A. Angiology; 2009 Mar; 60(3):308-17. PubMed ID: 18505742 [Abstract] [Full Text] [Related]
23. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women. Archer DF. Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205 [Abstract] [Full Text] [Related]
24. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G. J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119 [Abstract] [Full Text] [Related]
27. Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation. Lobo RA, Clarkson TB. Menopause; 2011 Feb; 18(2):237-40. PubMed ID: 21341399 [Abstract] [Full Text] [Related]
29. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Koledova VV, Khalil RA. Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655 [Abstract] [Full Text] [Related]
30. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence? Salpeter S. Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764 [Abstract] [Full Text] [Related]
32. Estrogen's protection against heart disease may be overstated. Indian Med Trib; 1994 Jul 15; 2(11):6. PubMed ID: 12179178 [Abstract] [Full Text] [Related]
33. Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Ettinger B. Maturitas; 2007 May 20; 57(1):81-4. PubMed ID: 17383126 [Abstract] [Full Text] [Related]
35. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators. Am J Epidemiol; 2005 Sep 01; 162(5):404-14. PubMed ID: 16033876 [Abstract] [Full Text] [Related]
36. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertüngealp J, Gompel A, Graziottin A, Hudita D, Pines A, Rozenberg S, Samsioe G, Stevenson JC, European Menopause and Andropause Society. Maturitas; 2005 May 16; 51(1):8-14. PubMed ID: 15883103 [Abstract] [Full Text] [Related]